184 related articles for article (PubMed ID: 25760304)
1. Beneficial effects of tripterygium glycosides tablet on biomarkers in patients with ankylosing spondylitis.
Ji W; Chen Y; Zhao X; Guo Y; Zhong L; Li H; Wang D; Song Y
Mol Med Rep; 2015 Jul; 12(1):684-90. PubMed ID: 25760304
[TBL] [Abstract][Full Text] [Related]
2. Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept.
Woo JH; Lee HJ; Sung IH; Kim TH
J Rheumatol; 2007 Aug; 34(8):1753-9. PubMed ID: 17610317
[TBL] [Abstract][Full Text] [Related]
3. Effect of tumour necrosis factor-α inhibitor on serum level of dickkopf-1 protein and bone morphogenetic protein-7 in ankylosing spondylitis patients with high disease activity.
Korkosz M; Gąsowski J; Leszczyński P; Pawlak-Buś K; Jeka S; Siedlar M; Grodzicki T
Scand J Rheumatol; 2014; 43(1):43-8. PubMed ID: 24447112
[TBL] [Abstract][Full Text] [Related]
4. Effects of
Ji W; Li H; Gao F; Chen Y; Zhong L; Wang D
Biomed Rep; 2014 Jul; 2(4):517-520. PubMed ID: 24944799
[TBL] [Abstract][Full Text] [Related]
5. [Effects of infliximab and etanercept, two types of anti-tumor necrosis factor-alpha inhibitor on serum level of matrix metalloproteinase 3 expression in patients with ankylosing spondylitis].
Yang CH; Huang F; Deng XH; Zhang JL; Zhang LY; Guo JH; Liang DF; Wang LS; Zhang YM
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2451-4. PubMed ID: 17156669
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of tripterygium glycosides tablet in treating ankylosing spondylitis: a systematic review and meta-analysis of randomized controlled trials.
Li H; Guo F; Luo YC; Zhu JP; Wang JL
Clin Rheumatol; 2015 Nov; 34(11):1831-8. PubMed ID: 26255190
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of adalimumab on biomarkers reflecting structural damage in patients with ankylosing spondylitis.
Maksymowych WP; Rahman P; Shojania K; Olszynski WP; Thomson GT; Ballal S; Wong RL; Inman RD;
J Rheumatol; 2008 Oct; 35(10):2030-7. PubMed ID: 18785308
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis.
Taylan A; Sari I; Akinci B; Bilge S; Kozaci D; Akar S; Colak A; Yalcin H; Gunay N; Akkoc N
BMC Musculoskelet Disord; 2012 Oct; 13():191. PubMed ID: 23025387
[TBL] [Abstract][Full Text] [Related]
9. Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis.
Maksymowych WP; Poole AR; Hiebert L; Webb A; Ionescu M; Lobanok T; King L; Davis JC
J Rheumatol; 2005 Oct; 32(10):1911-7. PubMed ID: 16206346
[TBL] [Abstract][Full Text] [Related]
10. The VEGF and BMP-2 levels in patients with ankylosing spondylitis and the relationship to treatment with tumour necrosis factor alpha inhibitors.
Tošovský M; Bradna P; Andrýs C; Andrýsová K; Cermáková E; Soukup T
Acta Medica (Hradec Kralove); 2014; 57(2):56-61. PubMed ID: 25257151
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of periostin and factors associated with new bone formation in ankylosing spondylitis: Periostin may be associated with the Wnt pathway.
Solmaz D; Uslu S; Kozacı D; Karaca N; Bulbul H; Tarhan EF; Ozmen M; Can G; Akar S
Int J Rheum Dis; 2018 Feb; 21(2):502-509. PubMed ID: 28941122
[TBL] [Abstract][Full Text] [Related]
12. ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors.
Pedersen SJ; Sørensen IJ; Garnero P; Johansen JS; Madsen OR; Tvede N; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen K; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Skjødt T; Lambert R; Hansen A; Østergaard M
Ann Rheum Dis; 2011 Aug; 70(8):1375-81. PubMed ID: 21551511
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study of etanercept for treating ankylosing spondylitis].
Liang LQ; Zhan ZP; Ye YJ; Fu D; Xu HS; Yang XY
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1349-51. PubMed ID: 18753057
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of Dkk-1, sclerostin and VEGF in patients with ankylosing spondylitis and their association with smoking, and clinical, inflammatory and radiographic parameters.
Sakellariou GT; Iliopoulos A; Konsta M; Kenanidis E; Potoupnis M; Tsiridis E; Gavana E; Sayegh FE
Joint Bone Spine; 2017 May; 84(3):309-315. PubMed ID: 27369645
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers of bone metabolism in ankylosing spondylitis in relation to osteoproliferation and osteoporosis.
Klingberg E; Nurkkala M; Carlsten H; Forsblad-d'Elia H
J Rheumatol; 2014 Jul; 41(7):1349-56. PubMed ID: 24931960
[TBL] [Abstract][Full Text] [Related]
16. Protective Effect and Possible Mechanisms of Tripterygium Glycosides in Patients with Ankylosing Spondylitis: A Systematic Review and Meta-Analysis.
Lin Z; Chen M; Chen X; Chen J; Zhang W
Oxid Med Cell Longev; 2022; 2022():9374895. PubMed ID: 35281463
[TBL] [Abstract][Full Text] [Related]
17. Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis.
de Vries MK; van Eijk IC; van der Horst-Bruinsma IE; Peters MJ; Nurmohamed MT; Dijkmans BA; Hazenberg BP; Wolbink GJ
Arthritis Rheum; 2009 Nov; 61(11):1484-90. PubMed ID: 19877087
[TBL] [Abstract][Full Text] [Related]
18. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.
Chen CH; Lin KC; Yu DT; Yang C; Huang F; Chen HA; Liang TH; Liao HT; Tsai CY; Wei JC; Chou CT
Rheumatology (Oxford); 2006 Apr; 45(4):414-20. PubMed ID: 16287916
[TBL] [Abstract][Full Text] [Related]
19. Changes of serum levels of MMP-3, sRANKL, and OPG in juvenile-onset ankylosing spondylitis patients carrying different HLA-B27 subtypes.
Mou YK; Zhang PP; Li QX; Lin ZM; Liao ZT; Wei QJ; Gu JR
Clin Rheumatol; 2015 Jun; 34(6):1085-9. PubMed ID: 25912212
[TBL] [Abstract][Full Text] [Related]
20. Circulating periostin levels in patients with AS: association with clinical and radiographic variables, inflammatory markers and molecules involved in bone formation.
Sakellariou GT; Anastasilakis AD; Bisbinas I; Oikonomou D; Gerou S; Polyzos SA; Sayegh FE
Rheumatology (Oxford); 2015 May; 54(5):908-14. PubMed ID: 25349442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
